Association of Surgical Hematoma Evacuation vs Conservative Treatment With Functional Outcome in Patients With Cerebellar Intracerebral Hemorrhage.


Journal

JAMA
ISSN: 1538-3598
Titre abrégé: JAMA
Pays: United States
ID NLM: 7501160

Informations de publication

Date de publication:
08 10 2019
Historique:
entrez: 9 10 2019
pubmed: 9 10 2019
medline: 24 10 2019
Statut: ppublish

Résumé

The association of surgical hematoma evacuation with clinical outcomes in patients with cerebellar intracerebral hemorrhage (ICH) has not been established. To determine the association of surgical hematoma evacuation with clinical outcomes in cerebellar ICH. Individual participant data (IPD) meta-analysis of 4 observational ICH studies incorporating 6580 patients treated at 64 hospitals across the United States and Germany (2006-2015). Surgical hematoma evacuation vs conservative treatment. The primary outcome was functional disability evaluated by the modified Rankin Scale ([mRS] score range: 0, no functional deficit to 6, death) at 3 months; favorable (mRS, 0-3) vs unfavorable (mRS, 4-6). Secondary outcomes included survival at 3 months and at 12 months. Analyses included propensity score matching and covariate adjustment, and predicted probabilities were used to identify treatment-related cutoff values for cerebellar ICH. Among 578 patients with cerebellar ICH, propensity score-matched groups included 152 patients with surgical hematoma evacuation vs 152 patients with conservative treatment (age, 68.9 vs 69.2 years; men, 55.9% vs 51.3%; prior anticoagulation, 60.5% vs 63.8%; and median ICH volume, 20.5 cm3 vs 18.8 cm3). After adjustment, surgical hematoma evacuation vs conservative treatment was not significantly associated with likelihood of better functional disability at 3 months (30.9% vs 35.5%; adjusted odds ratio [AOR], 0.94 [95% CI, 0.81 to 1.09], P = .43; adjusted risk difference [ARD], -3.7% [95% CI, -8.7% to 1.2%]) but was significantly associated with greater probability of survival at 3 months (78.3% vs 61.2%; AOR, 1.25 [95% CI, 1.07 to 1.45], P = .005; ARD, 18.5% [95% CI, 13.8% to 23.2%]) and at 12 months (71.7% vs 57.2%; AOR, 1.21 [95% CI, 1.03 to 1.42], P = .02; ARD, 17.0% [95% CI, 11.5% to 22.6%]). A volume range of 12 to 15 cm3 was identified; below this level, surgical hematoma evacuation was associated with lower likelihood of favorable functional outcome (volume ≤12 cm3, 30.6% vs 62.3% [P = .003]; ARD, -34.7% [-38.8% to -30.6%]; P value for interaction, .01), and above, it was associated with greater likelihood of survival (volume ≥15 cm3, 74.5% vs 45.1% [P < .001]; ARD, 28.2% [95% CI, 24.6% to 31.8%]; P value for interaction, .02). Among patients with cerebellar ICH, surgical hematoma evacuation, compared with conservative treatment, was not associated with improved functional outcome. Given the null primary outcome, investigation is necessary to establish whether there are differing associations based on hematoma volume.

Identifiants

pubmed: 31593272
pii: 2752468
doi: 10.1001/jama.2019.13014
pmc: PMC6784768
doi:

Types de publication

Comparative Study Journal Article Meta-Analysis Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1392-1403

Subventions

Organisme : NINDS NIH HHS
ID : P50 NS051343
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG026484
Pays : United States
Organisme : NINDS NIH HHS
ID : U01 NS069763
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS093870
Pays : United States

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Références

Control Clin Trials. 1986 Sep;7(3):177-88
pubmed: 3802833
Eur Heart J. 2018 May 14;39(19):1709-1723
pubmed: 29529259
Crit Care Med. 2019 Feb;47(2):176-185
pubmed: 30543566
Stroke. 2013 Oct;44(10):e120-5
pubmed: 24021679
Lancet. 2017 Feb 11;389(10069):603-611
pubmed: 28081952
Eur Neurol. 2004;52(2):112-9
pubmed: 15319556
Stroke. 2018 Nov;49(11):2621-2629
pubmed: 30355188
JAMA. 2018 Jun 5;319(21):2190-2201
pubmed: 29872859
Intensive Care Med. 2015 Feb;41(2):348-50
pubmed: 25578679
Stroke. 2015 Jul;46(7):2032-60
pubmed: 26022637
Stroke. 2009 Feb;40(2):569-76
pubmed: 18988914
JAMA. 2016 Sep 27;316(12):1279-88
pubmed: 27673305
Neurol Res. 1984 Sep;6(3):145-51
pubmed: 6151139
Nat Rev Neurosci. 2005 Apr;6(4):297-311
pubmed: 15803161
Lancet Glob Health. 2013 Nov;1(5):e259-81
pubmed: 25104492
JAMA. 2018 Feb 6;319(5):463-473
pubmed: 29372247
BMJ. 2016 Oct 12;355:i4919
pubmed: 27733354
J Eval Clin Pract. 2008 Oct;14(5):951-7
pubmed: 19018930
Int J Stroke. 2014 Oct;9(7):838-9
pubmed: 25231578
Stat Med. 2017 Feb 28;36(5):855-875
pubmed: 27747915
Lancet Neurol. 2009 Apr;8(4):326-33
pubmed: 19269254
Acta Neurochir (Wien). 1994;131(1-2):59-66
pubmed: 7709785
JAMA. 2015 Apr 28;313(16):1657-65
pubmed: 25919529
Eur Heart J. 2013 Oct;34(39):3028-34
pubmed: 24014390
Lancet Neurol. 2007 Mar;6(3):215-22
pubmed: 17303527
Stroke. 1996 Aug;27(8):1304-5
pubmed: 8711791
Clin Neurol Neurosurg. 2017 Apr;155:22-29
pubmed: 28226284
N Engl J Med. 2016 Sep 15;375(11):1033-43
pubmed: 27276234
JAMA. 2015 Feb 24;313(8):824-36
pubmed: 25710659
Acta Neurochir (Wien). 1993;122(3-4):187-93
pubmed: 8372706
Neurology. 2017 Aug 1;89(5):423-431
pubmed: 28679602
Ann Neurol. 2018 Jan;83(1):186-196
pubmed: 29314216
J Neurol. 2014 Feb;261(2):324-9
pubmed: 24297364
Neurol Clin. 2014 Nov;32(4):993-1007
pubmed: 25439293

Auteurs

Joji B Kuramatsu (JB)

Department of Neurology, University of Erlangen-Nuremberg, Erlangen, Germany.

Alessandro Biffi (A)

Department of Neurology, Massachusetts General Hospital, Boston.
Hemorrhagic Stroke Research Program, J. Philip Kistler Stroke Research Center, Boston, Massachusetts.

Stefan T Gerner (ST)

Department of Neurology, University of Erlangen-Nuremberg, Erlangen, Germany.

Jochen A Sembill (JA)

Department of Neurology, University of Erlangen-Nuremberg, Erlangen, Germany.

Maximilian I Sprügel (MI)

Department of Neurology, University of Erlangen-Nuremberg, Erlangen, Germany.

Audrey Leasure (A)

Department of Neurology, Yale University School of Medicine, New Haven, Connecticut.

Lauren Sansing (L)

Department of Neurology, Yale University School of Medicine, New Haven, Connecticut.

Charles Matouk (C)

Department of Neurology, Yale University School of Medicine, New Haven, Connecticut.

Guido J Falcone (GJ)

Department of Neurology, Yale University School of Medicine, New Haven, Connecticut.

Matthias Endres (M)

Department of Neurology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Center for Stroke Research Berlin, Charité-Universitätsmedizin Berlin, Berlin, Germany.
German Centre for Cardiovascular Research (DZHK), Berlin, Germany.
German Center for Neurodegenerative Diseases (DZNE), partner site Berlin, Berlin, Germany.

Karl Georg Haeusler (KG)

Department of Neurology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Center for Stroke Research Berlin, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Department of Neurology, University of Würzburg, Würzburg, Germany.

Jan Sobesky (J)

Department of Neurology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Center for Stroke Research Berlin, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Johannes Schurig (J)

Center for Stroke Research Berlin, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Sarah Zweynert (S)

Department of Neurology, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Miriam Bauer (M)

Center for Stroke Research Berlin, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Peter Vajkoczy (P)

Department of Neurosurgery, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Peter A Ringleb (PA)

Department of Neurology, Heidelberg University Hospital, Heidelberg, Germany.

Jan Purrucker (J)

Department of Neurology, Heidelberg University Hospital, Heidelberg, Germany.

Timolaos Rizos (T)

Department of Neurology, Heidelberg University Hospital, Heidelberg, Germany.
Department of Neurology, Alfried Krupp Krankenhaus Essen, Essen, Germany.

Jens Volkmann (J)

Department of Neurology, University of Würzburg, Würzburg, Germany.

Wolfgang Müllges (W)

Department of Neurology, University of Würzburg, Würzburg, Germany.

Peter Kraft (P)

Department of Neurology, University of Würzburg, Würzburg, Germany.

Anna-Lena Schubert (AL)

Department of Neurology, University of Würzburg, Würzburg, Germany.

Frank Erbguth (F)

Department of Neurology, Community Hospital Nuremberg, Nuremberg, Germany.

Martin Nueckel (M)

Department of Neurology, Community Hospital Nuremberg, Nuremberg, Germany.

Peter D Schellinger (PD)

Department of Neurology and Neurogeriatry, Johannes Wesling Medical Center Minden, UK RUB, Minden, Germany.

Jörg Glahn (J)

Department of Neurology and Neurogeriatry, Johannes Wesling Medical Center Minden, UK RUB, Minden, Germany.

Ulrich J Knappe (UJ)

Department of Neurosurgery, Johannes Wesling Medical Center Minden, UK RUB, Minden, Germany.

Gereon R Fink (GR)

Department of Neurology, University of Cologne, Cologne, Germany.

Christian Dohmen (C)

Department of Neurology, University of Cologne, Cologne, Germany.

Henning Stetefeld (H)

Department of Neurology, University of Cologne, Cologne, Germany.

Anna Lena Fisse (AL)

Department of Neurology, University of Münster, Münster, Germany.

Jens Minnerup (J)

Department of Neurology, University of Münster, Münster, Germany.

Georg Hagemann (G)

Department of Neurology, Community Hospital Helios Klinikum Berlin-Buch, Berlin, Germany.

Florian Rakers (F)

Department of Neurology, Community Hospital Helios Klinikum Berlin-Buch, Berlin, Germany.

Heinz Reichmann (H)

Department of Neurology, University of Dresden, Dresden, Germany.

Hauke Schneider (H)

Department of Neurology, University of Dresden, Dresden, Germany.
Department of Neurology, Klinikum Augsburg, Augsburg, Germany.

Jan Rahmig (J)

Department of Neurology, University of Dresden, Dresden, Germany.

Albert Christian Ludolph (AC)

Department of Neurology, University of Ulm, Ulm, Germany.

Sebastian Stösser (S)

Department of Neurology, University of Ulm, Ulm, Germany.

Hermann Neugebauer (H)

Department of Neurology, University of Würzburg, Würzburg, Germany.
Department of Neurology, University of Ulm, Ulm, Germany.

Joachim Röther (J)

Department of Neurology, Community Hospital Asklepios Klinik Hamburg Altona, Hamburg, Germany.

Peter Michels (P)

Department of Neurology, Community Hospital Asklepios Klinik Hamburg Altona, Hamburg, Germany.

Michael Schwarz (M)

Department of Neurology, Community Hospital Klinikum Dortmund, Dortmund, Germany.

Gernot Reimann (G)

Department of Neurology, Community Hospital Klinikum Dortmund, Dortmund, Germany.

Hansjörg Bäzner (H)

Department of Neurology, Community Hospital Klinikum Stuttgart, Stuttgart, Germany.

Henning Schwert (H)

Department of Neurology, Community Hospital Klinikum Stuttgart, Stuttgart, Germany.

Joseph Claßen (J)

Department of Neurology, University of Leipzig, Leipzig, Germany.

Dominik Michalski (D)

Department of Neurology, University of Leipzig, Leipzig, Germany.

Armin Grau (A)

Department of Neurology, Community Hospital Klinikum der Stadt Ludwigshafen am Rhein, Ludwigshafen, Germany.

Frederick Palm (F)

Department of Neurology, Community Hospital Klinikum der Stadt Ludwigshafen am Rhein, Ludwigshafen, Germany.

Christian Urbanek (C)

Department of Neurology, Community Hospital Klinikum der Stadt Ludwigshafen am Rhein, Ludwigshafen, Germany.

Johannes C Wöhrle (JC)

Department of Neurology, Community Hospital Klinikum Koblenz, Koblenz, Germany.

Fahid Alshammari (F)

Department of Neurology, Community Hospital Klinikum Koblenz, Koblenz, Germany.

Markus Horn (M)

Department of Neurology, Community Hospital Bad Hersfeld, Bad Hersfeld, Germany.

Dirk Bahner (D)

Department of Neurology, Community Hospital Bad Hersfeld, Bad Hersfeld, Germany.

Otto W Witte (OW)

Department of Neurology, University of Jena, Jena, Germany.

Albrecht Günther (A)

Department of Neurology, University of Jena, Jena, Germany.

Gerhard F Hamann (GF)

Department of Neurology and Neurological Rehabilitation, Bezirkskrankenhaus Günzburg, Günzburg, Germany.

Manuel Hagen (M)

Department of Neurology, University of Erlangen-Nuremberg, Erlangen, Germany.

Sebastian S Roeder (SS)

Department of Neurology, University of Erlangen-Nuremberg, Erlangen, Germany.

Hannes Lücking (H)

Department of Neuroradiology, University of Erlangen-Nuremberg, Erlangen, Germany.

Arnd Dörfler (A)

Department of Neuroradiology, University of Erlangen-Nuremberg, Erlangen, Germany.

Fernando D Testai (FD)

Department of Neurology and Rehabilitation, University of Illinois College of Medicine, Chicago.

Daniel Woo (D)

Department of Neurology and Rehabilitation Medicine, University of Cincinnati, Cincinnati, Ohio.

Stefan Schwab (S)

Department of Neurology, University of Erlangen-Nuremberg, Erlangen, Germany.

Kevin N Sheth (KN)

Department of Neurology, Yale University School of Medicine, New Haven, Connecticut.

Hagen B Huttner (HB)

Department of Neurology, University of Erlangen-Nuremberg, Erlangen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH